GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
Gargett T, Ebert LM, Truong NTH, Kollis PM, Sedivakova K, Yu W, Yeo ECF, Wittwer NL, Gliddon BL, Tea MN, Ormsby R, Poonnoose S, Nowicki J, Vittorio O, Ziegler DS, Pitson SM, Brown MP.
Gargett T, et al. Among authors: wittwer nl.
J Immunother Cancer. 2022 Sep;10(9):e005187. doi: 10.1136/jitc-2022-005187.
J Immunother Cancer. 2022.
PMID: 36167468
Free PMC article.